Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03354234Not ApplicableCompleted

Evaluation of the ORTHO-LBNP System

Role: collaborator

NCT05961644Phase 2Recruiting

Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).

Role: collaborator

NCT02192138Not ApplicableCompleted

Pathophysiological Effects of Intrapleural Pressure Changes During Therapeutic Thoracentesis

Role: collaborator

NCT02902588Not ApplicableTerminated

Blood-brain Barrier Permeability Study in Adults With Meningitis

Role: lead

NCT03640741Completed

Changes in Cerebral Oxygenation Studies During Laparoscopy Procedure

Role: lead

NCT02403427Not ApplicableUnknown

The Expert System VoiceDiab in Children With Diabetes

Role: collaborator

All 6 trials loaded